[1]陈孝平, 陈汉.肝胆外科学[M].北京:人民卫生出版社, 2005:481-482.
|
[2]Blechacz BR, Gores GJ.Cholangiocarcinoma[J].ClinLiver Dis, 2008, 12 (1) :131-150.
|
[3]Tanaka T, Akatsuka S, Ozeki M, et al.Redox regulationof annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis[J].Oncogene, 2004, 23 (22) :3980-3989.
|
[4]Huang Y, Jin Y, Yan CH, et al.Involvement of AnnexinA2in P53 induced apoptosis in lung cancer[J].Mol CellBiochem, 2008, 309 (1/2) :117-123.
|
[5]Vilar E, Salazar R, Pérez-García J, et al.Chemothe-rapy and role of the proliferation marker Ki-67 indigestive neuroendocrine tumors[J].Endocr RelatCancer, 2007, 14 (2) :221-232.
|
[6]纪小龙, 施作霖.诊断免疫组织化学[M].北京:军事医学科学出版社, 1997:12-31.
|
[7]Burke EC, Jarnagin WR, Hochwald SN, et al.Hilarcholangiocarcinoma:patterns of spread, the importanceof hepatic resection for curative operation, and apresurgical clinical staging system[J].Ann Surg, 1998, 228 (3) :385-394.
|
[8]Isa T, Tomita S, Nakaehi A, et al.Analysis of microsatelliteinstability, K-ras gene mutation and P53 protein overexpression intrahepatic cholangiocarcinoma[J].Hepatogastroenterology, 2002, 49 (3) :604-608.
|
[9]Luo W, Yan G, Li L, et al.Epstein-Barr virus latentmembrane protein 1 mediates serine 25 phosphorylationand nuclear entry of Annexin A2 via PI-PLC-PKCα/PKCβpathway[J].Mol Carcinog, 2008, 47 (12) :934-946.
|
[10]Barwe SP, Anilkumar G, Moon SY, et al.Novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signalingand suppression of cell motility[J].Mol Biol Cell, 2005, 16 (3) :1082-1094.
|
[11]赵玲, 崔全才.Annexin A2在肿瘤发生中的作用研究进展[J].中华病理学杂志, 2007, 36 (2) :129-132.
|
[12]萧笑, 王元, 张思河.钙依赖性磷脂结合蛋白AnnexinⅡ的研究进展[J].第四军医大学学报, 2007, 28 (6) :570-573.
|
[13]Chetcuti A, Margan S H, Russell P, et al.Loss ofannexinⅡheavy and light chains in prostate cancer andits precursors[J].Cancer Res, 2001, 61 (3) :6331-6334.
|
[14]宋魏, 仇晓菲.AnnexinⅡ与肿瘤的研究进展[J].医学综述, 2008, 14 (6) :851-853.
|
[15]Scholzen T, Gerdes J.The Ki-67 protein:from the knownand the unknown[J].J Cell Physiol, 2000, 182 (3) :311-322.
|
[16]Pinder SE, Wencyk P, Sibbering DM, et al.Assessment ofthe new proliferation marker MIB1 in breast carcinomausing image analysis:associations with other prognosticfactors and survival[J].Br J Cancer, 1995, 71 (1) :146-149.
|
[17]Schindlbeck C, Hantschmann P, Zerzer M, et al.Prognostic impact of KI67, p53, human epithelialgrowth factor receptor 2, topoisomerase IIα, epidermalgrowth factor receptor, and nm23 expression of ovariancarcinomas and disseminated tumor cells in the bonemarrow[J].Cancer, 2007, 17 (5) :1047-1055.
|